Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CTVA vs GSK✓SelectedUSD · GSKCTVA vs GSK performance historyLatest closeAs of-4.14%11/16
Stock and ETF performance explorer

CTVA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+127.4%
GSK return
+74.1%
Excess return
+53.3%
Maximum drawdown
-37.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.1%-0.1%-4.1%-4.1%
7D-25.4%-1.3%-24.0%-25.0%
30D-29.8%+2.7%-32.5%-30.4%
3M-21.3%+2.7%-24.0%-22.1%
6M-26.4%+3.3%-29.7%-27.5%
YTD-9.5%+6.5%-16.0%-12.5%
1Y-7.9%+10.7%-18.5%-12.2%
3Y+32.4%+64.4%-31.9%+3.7%
5Y+30.8%+46.7%-15.9%+5.5%
All+127.4%+74.1%+53.3%+73.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling